MS Pharma, based in Jordan and operating across the Middle East, Turkey and Africa, has entered into an agreement to acquire Genepharm, a European pharmaceutical company. Genepharm’s senior management will remain to help guide the company through the next phase of its growth. The transaction is expected to close in April.   Based in Greece, Genepharm develops, manufactures and out-licenses high-value generic pharmaceutical products and has an extensive network of 223 customers across 70 ...